Sanofi begins trial of Kevzara against COVID-19 complication...

Sanofi and Regeneron are throwing an already-approved drug at COVID-19, testing Kevzara (sarilumab) in patients hospitalised with severe disease.

UK court imposes safety rules on off-label use of Avastin in...

Bayer has said a new UK court ruling could limit off-label use of Roche's Avastin in ophthalmology by imposing stricter safety and consent measures.

Pharma steps up as coronavirus cases soar to 400,000-plus

New combination trial firms up Venclexta’s prospects in AML

Roche begins phase 3 trial of Actemra in COVID-19 pneumonia

Roche is to begin a phase 3 trial of its Actemra/RoActemra as a treatment for patients hospitalised with severe COVID-19 pneumonia, following independent research in China suggesting it may

Large scale tests for coronavirus 'unfeasible', says Roche C...

Widespread testing for the coronavirus is still unfeasible, Roche’s CEO Severin Schwan said in a press briefing on the coronavirus outbreak from industry leaders.